Literature DB >> 7629053

Using purified P-glycoprotein to understand multidrug resistance.

A B Shapiro1, V Ling.   

Abstract

Since P-glycoprotein was discovered almost 20 years ago, its causative role in multidrug resistance has been established, but central problems of its biochemistry have not been definitively resolved. Recently, major advances have been made in P-glycoprotein biochemistry with the use of purified and reconstituted P-glycoprotein, as well as membranes from nonmammalian cells containing heterologously expressed P-glycoprotein. In this review we describe recent findings using these systems which are elucidating the molecular mechanism of P-glycoprotein-mediated drug transport.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7629053     DOI: 10.1007/bf02110325

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  89 in total

1.  Domain mapping of the photoaffinity drug-binding sites in P-glycoprotein encoded by mouse mdr1b.

Authors:  L M Greenberger; C J Lisanti; J T Silva; S B Horwitz
Journal:  J Biol Chem       Date:  1991-11-05       Impact factor: 5.157

2.  Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells.

Authors:  H Hamada; T Tsuruo
Journal:  Cancer Res       Date:  1988-09-01       Impact factor: 12.701

3.  Study of membrane orientation and glycosylated extracellular loops of mouse P-glycoprotein by in vitro translation.

Authors:  J T Zhang; V Ling
Journal:  J Biol Chem       Date:  1991-09-25       Impact factor: 5.157

Review 4.  Structure and function of P-glycoprotein in normal liver and small intestine.

Authors:  Z C Gatmaitan; I M Arias
Journal:  Adv Pharmacol       Date:  1993

5.  Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers.

Authors:  A R Safa; C J Glover; J L Sewell; M B Meyers; J L Biedler; R L Felsted
Journal:  J Biol Chem       Date:  1987-06-05       Impact factor: 5.157

6.  Volume-activated chloride current is not related to P-glycoprotein overexpression.

Authors:  Y Dong; K G Chen; G E Durán; K Kouyama; A C Chao; B I Sikic; S V Gollapudi; S Gupta; P Gardner
Journal:  Cancer Res       Date:  1994-10-01       Impact factor: 12.701

7.  Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells.

Authors:  A R Safa; C J Glover; M B Meyers; J L Biedler; R L Felsted
Journal:  J Biol Chem       Date:  1986-05-15       Impact factor: 5.157

8.  The multidrug resistance (mdr1) gene product functions as an ATP channel.

Authors:  E H Abraham; A G Prat; L Gerweck; T Seneveratne; R J Arceci; R Kramer; G Guidotti; H F Cantiello
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

9.  Progesterone photoaffinity labels P-glycoprotein in multidrug-resistant human leukemic lymphoblasts.

Authors:  X D Qian; W T Beck
Journal:  J Biol Chem       Date:  1990-11-05       Impact factor: 5.157

10.  Diversity of multidrug resistance in mammalian cells.

Authors:  S E Devine; P W Melera
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

View more
  8 in total

Review 1.  Cellular drug efflux and reversal therapy of cancer.

Authors:  P W Wigler
Journal:  J Bioenerg Biomembr       Date:  1996-06       Impact factor: 2.945

Review 2.  Proton-dependent multidrug efflux systems.

Authors:  I T Paulsen; M H Brown; R A Skurray
Journal:  Microbiol Rev       Date:  1996-12

3.  A Network Biology Approach to Decipher Stress Response in Bacteria Using Escherichia coli As a Model.

Authors:  Shashwat Deepali Nagar; Bhavye Aggarwal; Shikha Joon; Rakesh Bhatnagar; Sonika Bhatnagar
Journal:  OMICS       Date:  2016-05

Review 4.  Preface: the concept and consequences of multidrug resistance.

Authors:  Jonathan A Sheps; Victor Ling
Journal:  Pflugers Arch       Date:  2006-07-22       Impact factor: 3.657

Review 5.  Altered drug translocation mediated by the MDR protein: direct, indirect, or both?

Authors:  P D Roepe; L Y Wei; M M Hoffman; F Fritz
Journal:  J Bioenerg Biomembr       Date:  1996-12       Impact factor: 2.945

6.  Edoxaban drug-drug interactions with ketoconazole, erythromycin, and cyclosporine.

Authors:  Dolly A Parasrampuria; Jeanne Mendell; Minggao Shi; Nobuko Matsushima; Hamim Zahir; Kenneth Truitt
Journal:  Br J Clin Pharmacol       Date:  2016-09-23       Impact factor: 4.335

7.  Quercetin as a potential modulator of P-glycoprotein expression and function in cells of human pancreatic carcinoma line resistant to daunorubicin.

Authors:  Sylwia Borska; Miroslaw Sopel; Magdalena Chmielewska; Maciej Zabel; Piotr Dziegiel
Journal:  Molecules       Date:  2010-02-09       Impact factor: 4.411

8.  Cancer: a single disease with a multitude of manifestions?

Authors:  Peter Grandics
Journal:  J Carcinog       Date:  2003-11-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.